EXOGENE
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well as safe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
EXOGENE
Social Links:
Industry:
Artificial Intelligence Biotechnology Life Science Pharmaceutical
Founded:
2019-11-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.exogene.co.uk
Total Employee:
1+
Status:
Active
Total Funding:
2.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Numerate
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Soltego
Soltego is a biotechnology company leveraging the skin’s pigmentation power for therapeutic and aesthetic applications.
Spring Discovery
Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.
Current Advisors List
Current Employees Featured
Founder
Investors List
Jude Gomila
Jude Gomila investment in Pre Seed Round - Exogene
Nadav Rosenberg
Nadav Rosenberg investment in Pre Seed Round - Exogene
R42 Group
R42 Group investment in Pre Seed Round - Exogene
Stefano Bernardi
Stefano Bernardi investment in Pre Seed Round - Exogene
KQ Labs
KQ Labs investment in Pre Seed Round - Exogene
Selvedge Venture
Selvedge Venture investment in Pre Seed Round - Exogene
Entrepreneur First
Entrepreneur First investment in Pre Seed Round - Exogene
Entrepreneur First
Entrepreneur First investment in Convertible Note - Exogene
Official Site Inspections
http://www.exogene.co.uk
- Host name: 495654.cloudwaysapps.com
- IP address: 167.99.88.128
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Exogene"
Exogene – Unlocking curative TCR-based therapies
Exogene is a techbio startup using deep learning to unlock the discovery of innovative ... PhD in Molecular and Computational Oncology from the University of Oxford and has previously …See details»
Exogene - Crunchbase Company Profile & Funding
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput …See details»
Exogene Company Profile | Management and Employees List
Www.exogene.co.uk . Exogene Profile and History. Exogene is a venture-backed biotechnology company combining generative AI and high-throughput lab experiments to design high-affinity, …See details»
Exogene Announces Strategic Collaboration with Immunocore To …
4th March, 2024. Oxford, UNITED KINGDOM. Exogene, a pioneer in the use of generative artificial intelligence (AI) for T-cell receptor (TCR) engineering, has entered into a research …See details»
Exogene - LinkedIn
Exogene | 1,476 followers on LinkedIn. AI-enabled design of high-affinity, cancer-specific T-cell receptors. | Exogene is a venture-backed biotechnology company combining generative AI and high ...See details»
Introducing Exogene — The Oxford Bioescalator
Exogene is a biotechnology company discovering novel T-cell receptor (TCR)-based cell therapies to treat advanced solid tumours. ... PhD in Molecular and Computational Oncology …See details»
Exogene - VentureRadar
Exogene is a biotechnology company enabling the discovery of T-cell-receptor (TCR)-based cell therapies to tackle solid tumors and reverse immune aging, by combining artificial intelligence …See details»
Exogene - Overview, News & Similar companies | ZoomInfo.com
Who is Exogene. Exogene is a venture-backed biotechnology company enabling the discovery of T-cell-receptor (TCR)-based cell therapies to tackle solid tumors and r everse immune aging, …See details»
Exogene - Products, Competitors, Financials, Employees, …
Exogene Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine …See details»
Exogene raises $2 million for its AI platform to discover cell ...
Oxford, UK, 28th April 2022 / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its …See details»
Exogene - Creative Destruction Lab
Exogene is a biotechnology startup accelerating the discovery of T-cell-receptor(TCR)-based cell therapies for otherwise untreatable solid tumors. They are building a machine learning platform to comprehensively screen TCRs …See details»
Exogene | VentureRadar
Exogene is a biotechnology company enabling the discovery of T-cell-receptor (TCR)-based cell therapies to tackle solid tumors and reverse immune aging, by combining artificial intelligence …See details»
Introducing Exogene — BioEscalator
Jun 1, 2021 Exogene's artificial intelligence platform rapidly screens billions of TCRs from patients in order to computationally identify and create TCRs that can target and destroy …See details»
This week: Exogene secures $2 million to advance its AI platform …
Apr 29, 2022 Exogene secures $2 million to advance its AI platform for solid-tumor cancer cell therapies Exogene (Oxford, UK), a biotechnology company dedicated to the discovery of novel …See details»
Exogene Raises $2 million for its AI platform to Discover Cell ...
Oxford, UK, 25th April 2022 / Sciad Newswire / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding …See details»
Exogene Raises $2M (£1.5M) for Its AI Platform to Discover Cell ...
Apr 27, 2022 Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, has raised $2M in funding to develop its artificial intelligence (AI) platform for T-cell …See details»
Exogene - Nature
Exogene www.exogene.co.uk How artificial intelligence is enabling T cell receptor screening for cell therapy discovery Exogene is using artificial intelligence to find rare, natural T cell ...See details»
Operations Manager - Exogene
Dec 19, 2022 About Exogene Exogene is an early-stage biotechnology startup combining artificial intelligence (AI), biophysical simulations and advanced high-throughput TCR …See details»
Exogene raises $2 million for its AI platform to discover cell ...
Oxford, UK, 25th April 2022 / Sciad Newswire / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding …See details»
News – Exogene
Apr 28, 2022 Continue Reading Exogene Announces Strategic Collaboration with Immunocore To Engineer T-Cell Receptors Using Artificial Intelligence. ... Post category: Oxford, UK, 28th …See details»